Cozaar vs Avapro: Cost, Dosing, and ARB Comparison
Cozaar (losartan) costs $4-$10 generic monthly vs pricier ARB alternatives like Avapro. Compare dosing, half-life, and trial data before switching.
25 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 25 of 25 clinical reviews.
Cozaar (losartan) costs $4-$10 generic monthly vs pricier ARB alternatives like Avapro. Compare dosing, half-life, and trial data before switching.
Combining losartan with spironolactone raises hyperkalemia risk via dual RAAS blockade; pharmacists should monitor serum potassium and renal function closely.
Does losartan affect appetite or food cravings? An evidence-based analysis of losartan's metabolic effects, the LIFE trial, RAAS-appetite links, and what patients should expect.
An evidence-based guide to using losartan in patients with autoimmune conditions, covering immunomodulatory mechanisms, drug interactions, organ-specific considerations, and monitoring protocols.
Standard losartan starting dose for adults is 50 mg once daily, titrated up to 100 mg if blood pressure stays above goal after several weeks.
How liver disease affects losartan metabolism, why dose reduction matters, and what clinicians should know about prescribing losartan in patients with hepatic impairment.
Losartan dosing in kidney disease, creatinine and potassium follow-up, and what RENAAL and STOP-ACEi show about continuing treatment as eGFR falls.
Losartan is an angiotensin II receptor blocker taken 25-100 mg once daily; it raises potassium, so watch salt substitutes, NSAIDs and St. John's Wort.
Losartan dosing after age 65: when 25 or 50 mg is used, kidney and potassium monitoring, trial results, dose timing and supervised medication reduction.
Evidence-based monitoring guide for losartan in adults 65 and older, covering renal function, potassium, blood pressure targets, fall risk, and drug interactions.
A clinical deep-dive into losartan's documented effects on hair and skin, including alopecia, psoriasiform reactions, and rare dermatologic adverse events, with primary-literature citations and prescriber guidance.
Evidence-based monitoring guide for adults aged 30 to 49 taking losartan. Covers baseline labs, follow-up intervals, potassium and creatinine targets, blood pressure goals, and when to adjust therapy.
Evidence-based monitoring guide for adults aged 50-64 taking losartan, covering kidney function, potassium, blood pressure targets, polypharmacy, and follow-up lab schedules.
A clinical guide to monitoring losartan in young adults aged 18 to 29, covering baseline labs, potassium and kidney function checks, blood pressure targets, fertility considerations, and long-term follow-up schedules.
Losartan extra-dose and overdose evidence: symptoms, actual poison-center findings, charcoal and dialysis limits, and exposure-specific assessment.
An evidence-based review of losartan pharmacokinetics covering absorption, distribution, CYP2C9-mediated metabolism to EXP3174, elimination, and how ADME properties shape dosing decisions.
A guide to losartan's safety profile during pregnancy and breastfeeding, covering mechanisms, trimester-specific risks, alternative agents, and FDA/ACOG guidance.
A guide to losartan safety in adults aged 30 to 49, covering side effects, contraindications, drug interactions, pregnancy risks, and monitoring protocols with cited trial evidence.
A guide to losartan safety for adults aged 50-64, covering side effects, hyperkalemia risk, kidney monitoring, polypharmacy concerns, and evidence from the LIFE trial.
Evidence-based guide to losartan safety in adults 65 and older, covering renal monitoring, fall risk, hyperkalemia, drug interactions, and deprescribing considerations.
A clinician-grade review of losartan's FDA safety history, including NDMA contamination recalls, black-box fetal toxicity warnings, hyperkalemia risk, and post-marketing surveillance data from the LIFE trial and beyond.
A guide to losartan storage conditions, chemical stability, shelf life, and what happens when tablets are exposed to heat, humidity, or light. Includes mechanism of action, key trial data, and FDA-cited evidence.
Before stopping losartan, identify its treatment goal, record current blood pressure and lab results, and confirm the plan with your prescriber.
Before switching losartan, check whether it treats blood pressure, diabetic kidney disease, or another condition, and what the replacement needs to do.
Losartan is an angiotensin II receptor blocker taken once daily, 25-100 mg. Miss a dose? Take it if 12+ hours remain before the next one; never double up.